Compare MBUU & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MBUU | CYRX |
|---|---|---|
| Founded | 1982 | 1999 |
| Country | United States | United States |
| Employees | 2200 | 1100 |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 493.7M | 419.3M |
| IPO Year | 2013 | 2008 |
| Metric | MBUU | CYRX |
|---|---|---|
| Price | $26.52 | $10.66 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $33.40 | $13.31 |
| AVG Volume (30 Days) | 335.5K | ★ 393.6K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 127.74 | ★ 156.22 |
| EPS | N/A | ★ 1.40 |
| Revenue | ★ $807,561,000.00 | $176,177,000.00 |
| Revenue This Year | $2.14 | $11.06 |
| Revenue Next Year | $12.78 | $8.45 |
| P/E Ratio | ★ N/A | $7.39 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $23.92 | $5.31 |
| 52 Week High | $39.65 | $11.45 |
| Indicator | MBUU | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 52.58 | 77.36 |
| Support Level | $24.30 | $9.18 |
| Resistance Level | $30.15 | $11.33 |
| Average True Range (ATR) | 1.17 | 0.41 |
| MACD | 0.26 | 0.18 |
| Stochastic Oscillator | 80.70 | 99.23 |
Malibu Boats is a designer and manufacturer of power boats in the United States. It is a market leader in performance sport boats, sold under its Malibu and Axis brands. It acquired Cobalt Boats, a producer of sterndrive boats, in 2017, and Pursuit Boats, which makes high end offshore and outboard motorboats in 2018. In 2021, it purchased Maverick Boat Group, a seller of flat fishing boats, with exposure to bay, dual console, and center console boats. Malibu has also expanded into boat trailers and accessories, and in 2020, began producing its own engines for its performance sport boats.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.